Guido Neels served as Chief
Operating Officer of Guidant Corporation, a world leader in the
development of cardiovascular medical products, from May 2004 until
retiring in November 2005. He was responsible for the global operations
of Guidant's four operating units: Cardiac Rhythm Management, Vascular
Intervention, Cardiac Surgery, and Endovascular Solutions. From December
2002 to May 2004, he was Group Chairman, Office of the President at
Guidant, responsible for worldwide sales operations, corporate
communications, corporate marketing, investor relations and government
relations. From January 2000 to December 2002, he was President of
Europe, Middle East, Africa and Canada. He previously served as Vice
President of Global Marketing for Vascular Intervention and as Managing
Director for German and Central European operations. From 1982 until
Guidant was spun off as an independent public company from Eli Lilly and
Co. in 1994, Mr. Neels held various general management and sales and
marketing positions at Lilly in Europe and the U.S. From 1972 to 1980,
he held positions in information technology, finance and manufacturing
at Raychem Corporation in Belgium and the U.S.
Mr. Neels has been an
independent director with Biopure Corporation since August 2005. He
serves on the Board of Directors for
Nellix and
Oraya. He also
holds Board positions at
LeMaitre Vascular, WMR Biomedical, EndGenitor Technologies, and Radiant
Medical.
He
holds a master of business administration degree from Stanford
University and a business engineering degree from the University of Leuven in Belgium.
|
